Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles. While many countries have seen a decline in investment in recent years, ...

The biotechnology company BeiGene, founded in China, is moving its legal headquarters from the Cayman Islands to Basel.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

The biotech – which was incubated by Swiss investment group Xlife Sciences – is also planning an additional financing round to top up its cash reserves even further as it works towards ...

BERLIN, April 23 (Reuters) - Swiss biotech investor Xlife Sciences AG (XLS.S), opens new tab said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 ...

If completed, it is thought that this would be the first IPO by a Swiss biotech since Polyphor – another antibiotic developer now called Spexis – went public in 2018. While there has been a ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested it may try to equalize through tariffs.

Filippo Mulinacci joined Araris Biotech in 2022 as its chief business officer. In March, the oncology company, based in Zurich, Switzerland, was acquired by Taiho Pharma, based in Tokyo ...